Immunic, Inc. (IMUX): Price and Financial Metrics


Immunic, Inc. (IMUX)

Today's Latest Price: $13.37 USD

0.50 (-3.60%)

Updated Jul 7 4:00pm

Add IMUX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 336 in Biotech

See all "A" rated Strong Buy stocks

IMUX Daily Price Range
IMUX 52-Week Price Range

IMUX Stock Price Chart Technical Analysis Charts


IMUX Price/Volume Stats

Current price $13.37 52-week high $19.05
Prev. close $13.87 52-week low $4.19
Day low $12.79 Volume 387,135
Day high $14.10 Avg. volume 179,350
50-day MA $11.31 Dividend yield N/A
200-day MA $9.03 Market Cap 200.12M

Immunic, Inc. (IMUX) Company Bio


Immunic Inc. (formerly Vital Therapies) is a biotherapeutic company developing a cell-based therapy targeting the treatment of liver failure. The company was founded in 2003 and is based in San Diego, California.


IMUX Latest News Stream


Event/TimeNews Detail
Loading, please wait...

IMUX Latest Social Stream


Loading social stream, please wait...

View Full IMUX Social Stream

Latest IMUX News From Around the Web

Below are the latest news stories about Immunic Inc that investors may wish to consider to help them evaluate IMUX as an investment opportunity.

3 “Strong Buy” Micro-Cap Stocks That Offer Attractive Returns

If you are looking to hit a home run in the stock market, the NASDAQ Composite is a good place to start. The index is home to surging technology, internet, and biotech stocks. Despite the adverse effects from COVID-19, the index is up 25% over the past year, and recently hit a new all-time high. Now comes the hard part. How are investors supposed to determine which stocks are poised to take off? Will the current winners continue climbing, or will new high-flyers emerge? Finding the next big one is challenging to say the least. On top of this, there are numerous and sometimes conflicting investing strategies to consider. Bearing this in mind, Wall Street analysts can provide some inspiration. The experts possess extensive knowledge about the stocks they cover, and offer insights on com...

Yahoo | July 5, 2020

ImmunoGen (IMGN) Investor Presentation - Slideshow

The following slide deck was published by Immunic, Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | June 24, 2020

Immunic joins Russell 3000 Index

Immunic (IMUX) is set to join the broad-market Russell 3000 Index, effective after the US market opens on June 29....

Seeking Alpha | June 22, 2020

Immunic, Inc. to Join Russell 3000® Index

Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced that the company is set to join the broad-market Russell 3000® Index at the conclusion of the 2020 Russell indexes annual reconstitution, effective after the US market opens on June 29, according to a final list of additions accessed on June 19.

Yahoo | June 22, 2020

Immunic, Inc. Announces First Patients Dosed in its Phase 2, CALVID-1 Clinical Trial of IMU-838 in COVID-19

Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced dosing of the first patients in its phase 2, CALVID-1 clinical trial of IMU-838, the company's selective oral DHODH inhibitor, in coronavirus disease 2019 (COVID-19), at several sites in different European countries. Patients will be enrolled at 10 to 35 centers in Germany, the United States and a half dozen European countries.

Yahoo | June 15, 2020

Read More 'IMUX' Stories Here

IMUX Price Returns

1-mo -2.90%
3-mo 105.69%
6-mo 45.80%
1-year 24.26%
3-year -88.47%
5-year -98.71%
YTD 37.84%
2019 27.63%
2018 -96.81%
2017 36.78%
2016 -62.24%
2015 -53.79%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7923 seconds.